PL2516435T3 - Inhibitory aktywności AKT - Google Patents
Inhibitory aktywności AKTInfo
- Publication number
- PL2516435T3 PL2516435T3 PL10800980T PL10800980T PL2516435T3 PL 2516435 T3 PL2516435 T3 PL 2516435T3 PL 10800980 T PL10800980 T PL 10800980T PL 10800980 T PL10800980 T PL 10800980T PL 2516435 T3 PL2516435 T3 PL 2516435T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- akt activity
- akt
- activity
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0922589.7A GB0922589D0 (en) | 2009-12-23 | 2009-12-23 | Pharmaceutical compounds |
| EP10800980.4A EP2516435B8 (en) | 2009-12-23 | 2010-12-23 | Inhibitors of akt activity |
| PCT/GB2010/002329 WO2011077098A1 (en) | 2009-12-23 | 2010-12-23 | Inhibitors of akt activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2516435T3 true PL2516435T3 (pl) | 2015-01-30 |
Family
ID=41716932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10800980T PL2516435T3 (pl) | 2009-12-23 | 2010-12-23 | Inhibitory aktywności AKT |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9221838B2 (pl) |
| EP (1) | EP2516435B8 (pl) |
| JP (1) | JP5923043B2 (pl) |
| KR (1) | KR20140015157A (pl) |
| CN (1) | CN102791708B (pl) |
| AU (1) | AU2010334591C1 (pl) |
| BR (1) | BR112012015677A2 (pl) |
| CA (1) | CA2783340C (pl) |
| CY (1) | CY1115686T1 (pl) |
| DK (1) | DK2516435T3 (pl) |
| ES (1) | ES2503794T3 (pl) |
| GB (1) | GB0922589D0 (pl) |
| IL (1) | IL220153A (pl) |
| MX (1) | MX2012007274A (pl) |
| NZ (1) | NZ600453A (pl) |
| PL (1) | PL2516435T3 (pl) |
| PT (1) | PT2516435E (pl) |
| RU (1) | RU2579513C2 (pl) |
| SG (1) | SG181517A1 (pl) |
| SI (1) | SI2516435T1 (pl) |
| WO (1) | WO2011077098A1 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201205164D0 (en) * | 2012-03-23 | 2012-05-09 | Almac Discovery Ltd | Pharmaceutical compounds |
| JP6787899B2 (ja) * | 2014-12-23 | 2020-11-18 | ベルゲンビオ アーエスアー | 医薬的活性化合物 |
| US10323044B2 (en) * | 2015-02-27 | 2019-06-18 | Taiho Pharmaceutical Co., Ltd. | Crystal of imidazo-oxazine, pharmaceutical composition containing said crystal, and method for producing said crystal |
| GB201603779D0 (en) | 2016-03-04 | 2016-04-20 | Mission Therapeutics Ltd | Novel compounds |
| MA45865A (fr) * | 2016-08-07 | 2021-04-14 | Wistar Inst | Procédés de détection et de traitement d'une tumeur exprimant pt346 pdk1 |
| UA125730C2 (uk) * | 2017-06-22 | 2022-05-25 | Курадев Фарма Лімітед | Низькомолекулярні модулятори sting людини |
| MX2020002611A (es) | 2017-09-07 | 2020-07-13 | Univ Res Inst Inc Augusta | Activador especifico de akt3 y usos del mismo. |
| GB2600384A (en) * | 2020-09-30 | 2022-05-04 | Vaderis Therapeutics Ag | Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia |
| WO2025250545A1 (en) * | 2024-05-28 | 2025-12-04 | Alterome Therapeutics, Inc. | Akt1 modulators |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL181893B1 (pl) * | 1994-11-14 | 2001-10-31 | Warner Lambert Co | Zwiazki bedace pochodnymi pirymidyny i naftyrydyny oraz preparat farmaceutyczny zawierajacy je PL PL PL |
| TWI301760B (en) * | 2004-02-27 | 2008-10-11 | Merz Pharma Gmbh & Co Kgaa | Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| US7910561B2 (en) * | 2004-12-15 | 2011-03-22 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
| EP1898903B8 (en) * | 2005-06-10 | 2013-05-15 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| WO2008011032A1 (en) * | 2006-07-17 | 2008-01-24 | Amgen Inc. | Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| JP2010512312A (ja) | 2006-12-06 | 2010-04-22 | メルク エンド カムパニー インコーポレーテッド | Ａｋｔ活性の阻害剤 |
| AR064010A1 (es) | 2006-12-06 | 2009-03-04 | Merck & Co Inc | Inhibidores de la actividad de la akt |
| US7999107B2 (en) * | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
| JP2011522048A (ja) * | 2008-06-03 | 2011-07-28 | メルク・シャープ・エンド・ドーム・コーポレイション | Ａｋｔ活性の阻害剤 |
| US8536193B2 (en) | 2008-06-03 | 2013-09-17 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
-
2009
- 2009-12-23 GB GBGB0922589.7A patent/GB0922589D0/en not_active Ceased
-
2010
- 2010-12-23 BR BRBR112012015677-2A patent/BR112012015677A2/pt not_active Application Discontinuation
- 2010-12-23 SG SG2012041232A patent/SG181517A1/en unknown
- 2010-12-23 US US13/517,219 patent/US9221838B2/en active Active
- 2010-12-23 CA CA2783340A patent/CA2783340C/en not_active Expired - Fee Related
- 2010-12-23 CN CN201080059321.9A patent/CN102791708B/zh active Active
- 2010-12-23 AU AU2010334591A patent/AU2010334591C1/en not_active Ceased
- 2010-12-23 JP JP2012545434A patent/JP5923043B2/ja active Active
- 2010-12-23 MX MX2012007274A patent/MX2012007274A/es active IP Right Grant
- 2010-12-23 PL PL10800980T patent/PL2516435T3/pl unknown
- 2010-12-23 DK DK10800980.4T patent/DK2516435T3/da active
- 2010-12-23 PT PT108009804T patent/PT2516435E/pt unknown
- 2010-12-23 EP EP10800980.4A patent/EP2516435B8/en active Active
- 2010-12-23 SI SI201030774T patent/SI2516435T1/sl unknown
- 2010-12-23 WO PCT/GB2010/002329 patent/WO2011077098A1/en not_active Ceased
- 2010-12-23 KR KR1020127019033A patent/KR20140015157A/ko not_active Ceased
- 2010-12-23 NZ NZ600453A patent/NZ600453A/xx not_active IP Right Cessation
- 2010-12-23 ES ES10800980.4T patent/ES2503794T3/es active Active
- 2010-12-23 RU RU2012131115/04A patent/RU2579513C2/ru not_active IP Right Cessation
-
2012
- 2012-06-04 IL IL220153A patent/IL220153A/en not_active IP Right Cessation
-
2014
- 2014-10-31 CY CY20141100899T patent/CY1115686T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5923043B2 (ja) | 2016-05-24 |
| SI2516435T1 (sl) | 2014-12-31 |
| RU2579513C2 (ru) | 2016-04-10 |
| ES2503794T3 (es) | 2014-10-07 |
| KR20140015157A (ko) | 2014-02-06 |
| MX2012007274A (es) | 2012-10-03 |
| AU2010334591B2 (en) | 2014-04-10 |
| GB0922589D0 (en) | 2010-02-10 |
| EP2516435B8 (en) | 2014-10-15 |
| AU2010334591C1 (en) | 2014-07-31 |
| IL220153A0 (en) | 2012-07-31 |
| BR112012015677A2 (pt) | 2015-06-30 |
| DK2516435T3 (da) | 2014-10-13 |
| EP2516435A1 (en) | 2012-10-31 |
| US9221838B2 (en) | 2015-12-29 |
| RU2012131115A (ru) | 2014-01-27 |
| HK1171013A1 (en) | 2013-03-15 |
| JP2013515710A (ja) | 2013-05-09 |
| US20130116243A1 (en) | 2013-05-09 |
| EP2516435B1 (en) | 2014-08-06 |
| CN102791708A (zh) | 2012-11-21 |
| IL220153A (en) | 2015-05-31 |
| NZ600453A (en) | 2013-10-25 |
| CA2783340C (en) | 2015-11-24 |
| CA2783340A1 (en) | 2011-06-30 |
| WO2011077098A1 (en) | 2011-06-30 |
| CY1115686T1 (el) | 2017-01-25 |
| WO2011077098A9 (en) | 2012-04-19 |
| CN102791708B (zh) | 2016-03-02 |
| AU2010334591A1 (en) | 2012-06-21 |
| PT2516435E (pt) | 2014-11-13 |
| SG181517A1 (en) | 2012-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL209488A0 (en) | Inhibitors of akt activity | |
| IL200212A0 (en) | Inhibitors of akt activity | |
| ZA201700326B (en) | Inhibitors of beta-secretase | |
| EP2114388A4 (en) | INHIBITORS OF AKT'S ACTIVITY | |
| EP2303852A4 (en) | ACTIVITY INHIBITORS AKT | |
| EP2440054A4 (en) | PYRIDILTRIA INHIBITOR OF HEDGEHOG SIGNALING | |
| ZA201203289B (en) | Use of bethanechol for treatment of zerostomia | |
| GB201004179D0 (en) | Enzyme inhibitors | |
| EP2306825A4 (en) | HAMMER OF ACT ACTIVITY | |
| GB201004178D0 (en) | Enzyme inhibitors | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| IL218018A0 (en) | Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions | |
| IL220153A0 (en) | Inhibitors of akt activity | |
| IL215645A0 (en) | Inhibitors of cognitive decline | |
| EP2134175A4 (en) | HAMMER OF ACT ACTIVITY | |
| IL217833A0 (en) | Inhibitors of cognitive decline | |
| PL2493496T3 (pl) | Zastosowanie GSTP1 | |
| EP2303277A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303017A4 (en) | HAMMER OF ACT ACTIVITY | |
| EP2303258A4 (en) | ACTIVITY INHIBITORS AKT | |
| PL2411376T3 (pl) | Inhibitory nf-kb | |
| GB0908609D0 (en) | New use of isoQC inhibitors | |
| AU2010301641B2 (en) | Heparanase activity inhibitor | |
| GB0903651D0 (en) | Inhibitors of glyoxalase | |
| HK1166320A (en) | Inhibitors of beta-secretase |